Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions

Evidence is mounting that potentially curative systemic adjuvant therapy for early-stage breast cancer may result in cognitive impairment. Five published studies have investigated cognitive function in this setting, and the consistent results of all five studies suggest an adverse effect of adjuvant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2003-02, Vol.95 (3), p.190-197
Hauptverfasser:	Phillips, Kelly-Anne, Bernhard, Jürg
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Antineoplastic Agents, Hormonal - administration & dosage Antineoplastic Agents, Hormonal - adverse effects Biological and medical sciences Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - psychology Breast Neoplasms - surgery Chemotherapy Chemotherapy, Adjuvant Cognition & reasoning Cognition - drug effects Cognition Disorders - chemically induced Drug therapy Estrogen Receptor Modulators - administration & dosage Estrogen Receptor Modulators - adverse effects Female Fundamental and applied biological sciences. Psychology Humans Medical sciences Menopause, Premature - psychology Miscellaneous Pharmacology. Drug treatments Psychology and medicine Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Side effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!